QRT has been shown to modulate the JAK/STAT pathway, which plays a pivotal role in immune response regulation and is often hyperactivated in various cancers, particularly in breast and hematologic malignancies and by inhibiting key components of this pathway, QRT can interfere with signals that promote cancer cell survival, proliferation, and immune evasion [118]. This evidence concerns the gene SOAT1 and cancer.